These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 12132444

  • 1. Infection fighters. Interferon and ribavirin for hepatitis B.
    TreatmentUpdate; 2001; 12(9):2-3. PubMed ID: 12132444
    [No Abstract] [Full Text] [Related]

  • 2. Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?
    Alberti A.
    J Hepatol; 2004 Jun; 40(6):1032-5. PubMed ID: 15158348
    [No Abstract] [Full Text] [Related]

  • 3. Infection fighters. Hepatitis C and HIV.
    TreatmentUpdate; 2005 Jun; 17(1):7. PubMed ID: 17225318
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic hepatitis C in patients without previous treatment].
    Dehesa Violante M.
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK, Kaplan AL.
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Theory and practice of pharmacotherapy of chronic hepatitis B].
    Juszczyk J.
    Przegl Epidemiol; 1989 Oct; 43(2):183-91. PubMed ID: 2479056
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
    Kumar KS, Russo MW, Borczuk AC, Brown M, Esposito SP, Lobritto SJ, Jacobson IM, Brown RS.
    Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Sep; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characteristics of and current treatment options for hepatitis B and hepatitis C.
    Adams P.
    J Can Dent Assoc; 2000 Nov; 66(10):537. PubMed ID: 12584770
    [No Abstract] [Full Text] [Related]

  • 15. Proceedings of an international symposium on anti-viral agents in chronic hepatitis B virus infection. London, U.K., 11-12 November 1985.
    J Hepatol; 1986 Nov; 3 Suppl 2():S1-317. PubMed ID: 2439567
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
    McGovern B, Bica I.
    Clin Infect Dis; 2003 Aug 01; 37(3):463-4; author reply 464-5. PubMed ID: 12884180
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of hepatitis C virus genotype 4.
    Abdo AA, Lee SS.
    J Gastroenterol Hepatol; 2004 Nov 01; 19(11):1233-9. PubMed ID: 15482528
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.